# Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

> **NCT03140449** · PHASE3 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 52 (actual)

## Conditions studied

- Facial Angiofibroma

## Interventions

- **DRUG:** Rapamycin
- **DRUG:** Calcitriol
- **DRUG:** Rapamycin-calcitriol combination

## Key facts

- **NCT ID:** NCT03140449
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-05
- **Primary completion:** 2016-11-07
- **Final completion:** 2017-04-25
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140449, "Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03140449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*